Clinical bottom line
Anesthetic management in bariatric surgery requires tailored approaches addressing the unique physiological challenges of obesity, including airway management, altered pharmacokinetics, and increased risk of perioperative complications. Current guidelines emphasize comprehensive preoperative assessment, multimodal analgesia to reduce opioid use, and proactive prevention of postoperative nausea and vomiting (PONV). Enhanced recovery protocols and intraoperative care pathways improve outcomes in minimally invasive procedures such as laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Despite advances, individualized care remains essential due to heterogeneity in patient comorbidities and surgical complexity (Mechanick et al., 2020; Debel et al., 2026).
What the evidence shows
Mechanick et al. (2020) provide updated clinical practice guidelines co-sponsored by major societies, recommending thorough preoperative evaluation of metabolic, nutritional, and cardiopulmonary status. They highlight the importance of optimizing comorbidities and planning airway management strategies given increased risk of difficult intubation.
Debel et al. (2026) update procedure-specific postoperative pain management (PROSPECT) recommendations for laparoscopic sleeve gastrectomy, endorsing multimodal analgesia including regional blocks and non-opioid adjuncts to minimize opioid-related respiratory depression.
Mieszczański et al. (2025) review evidence-based strategies for PONV prevention in laparoscopic bariatric surgery, advocating risk stratification and combination antiemetic prophylaxis to reduce incidence and improve patient comfort.
Lin et al. (2024) describe an intraoperative care pathway for minimally invasive Roux-en-Y gastric bypass, emphasizing standardized anesthetic protocols, fluid management, and early extubation to enhance recovery.
dos Reis Falcão et al. (2019) discuss perioperative anesthetic medication choices, noting altered drug distribution in obesity and recommending dose adjustments based on ideal or lean body weight to avoid toxicity.
Vaughns et al. (2021) address anesthetic considerations in adolescent bariatric surgery, underscoring the need for psychological support and tailored anesthetic plans in this population.
Caveats and uncertainty
Evidence is evolving, with many recommendations based on expert consensus or observational data rather than large RCTs.
Variability in patient phenotypes and surgical techniques limits generalizability.
Optimal dosing strategies for many anesthetic agents in severe obesity remain incompletely defined.
Long-term outcomes related to anesthetic management strategies are underreported.
Special populations, such as patients with Prader-Willi syndrome, require individualized approaches with limited data (Lijnzaat et al., 2017).
How this may change practice
Adoption of guideline-based perioperative pathways can standardize care and reduce complications.
Multimodal analgesia and PONV prophylaxis should be routine to enhance recovery and reduce opioid-related adverse events.
Preoperative optimization of comorbidities, including obstructive sleep apnea, is critical.
Anesthesiologists should apply weight-based dosing principles and anticipate airway challenges.
Integration of multidisciplinary teams including nutritionists, surgeons, and anesthesiologists will improve perioperative outcomes.
Ongoing research will refine pharmacologic protocols and identify best practices for diverse bariatric populations.